Clinical trials
Observational Neuroma, Acoustic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
| Completed | 7 |
| Recruiting | 6 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Christoph Arnoldner | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| University Hospital Tuebingen | 2 |
| University Hospital, Strasbourg, France | 2 |
| Akouos, Inc. | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Central Hospital, Nancy, France | 1 |
| Hartmann Oncology Radiotherapy Group, France | 1 |
| Haukeland University Hospital | 1 |
| House Ear Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroma, Acoustic | 26 |
| Hearing Loss | 4 |
| Neurofibromatosis 2 | 4 |
| Brain Neoplasms | 3 |
| Neurilemmoma | 3 |
| Meningioma | 2 |
| Neurofibromatoses | 2 |
| Brain Stem Neoplasms | 1 |
| Dizziness | 1 |
| Endolymphatic Hydrops | 1 |
Trials
Showing 51 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.